Tfdp2tm1c(EUCOMM)Wtsi
Targeted Allele Detail
|
Symbol: |
Tfdp2tm1c(EUCOMM)Wtsi |
Name: |
transcription factor Dp 2; targeted mutation 1c, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:6260183 |
Gene: |
Tfdp2 Location: Chr9:96078348-96205699 bp, + strand Genetic Position: Chr9, 50.31 cM, cytoband E4
|
Alliance: |
Tfdp2tm1c(EUCOMM)Wtsi page
|
IMPC: |
Tfdp2 gene page |
|
Mutant Cell Line: |
EPD0800_3_B10 |
Germline Transmission: |
Earliest citation of germline transmission:
J:101977
|
Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
Strain of Origin: |
C57BL/6N-Atm1Brd
|
Project Collection: |
EUCOMM
|
|
Allele Type: |
|
Targeted (Conditional ready) |
Mutation: |
|
Insertion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 96176307 of Chromosome 9 upstream of exon 5 (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of exon 6 at position 96180032. Exons 5 and 6 are thus flanked by loxP sites. Flp-mediated recombination removed the FRT-flanked neo cassette.
(J:155845)
|
|
|
|
Original: |
J:155845 Wellcome Trust Sanger Institute, Alleles produced for the EUCOMM and EUCOMMTools projects by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2010; |
All: |
2 reference(s) |
|